BioNTechs leadership: Pioneers shaping the future of medicine Prof Ugur Sahin, M D , Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel approaches to fight cancer and infectious diseases Sahin is one of the world’s foremost experts on messenger ribonucleic acid (mRNA) medicines
Uğur Şahin - Wikipedia He is the co-founder and CEO of BioNTech, which developed the world’s first mRNA-based vaccine against COVID-19 [3][4] He also serves as chairman of the scientific management board of the Helmholtz Institute for Translational Oncology [de] (HI-TRON), a Mainz -based cutting-edge biopharmaceutical research laboratory he co-founded in 2018 [5]
Ugur Sahin - Forbes Uğur Şahin is CEO and cofounder of German biotech firm BioNTech, which partnered with Pfizer to produce the first Covid-19 vaccine approved in the US
BioNTech Provides Strategic Business Update and Outlines 2026 Areas of . . . These achievements have successfully positioned us as a late-stage biopharmaceutical company,” said Prof Ugur Sahin, M D , Chief Executive Officer and Co-Founder of BioNTech “We see 2026 as a year when science translates into tangible results
Biontech SE at JPMorgan Healthcare Conference Transcript My name's Jess Fye I'm a biotech analyst at JPMorgan, and we're continuing our 44th Annual Healthcare Conference today with Biontech First, you're going to hear a presentation from the company, and then we're going to go into some Q A (Event Instructions) So with that out of the way, I'm pleased to introduce Biontech's CEO, Ugur Sahin
Kalender